Welcome to the future of genetic innovation! At QUiCKR Bio, we are pioneering accurate and quick genomics to accelerate cell and gene therapy development. Introducing QUiCKR V2, an in-house assay for the rapid and accurate quantification of editing outcomes, Viral Vector QC, and Genome Stability Testing. The assay runs on any standard plate reader in only 20 min and can scale to 100+ samples/hour. Reach out to learn more!
| Website | https://www.quickrbio.com |
| Employees | 6 (6 on RocketReach) |
| Industry | Biotechnology Research |
| Keywords | Cell Therapy, Gene Therapy, Genomics, Genetic Engineering, Biotechnology, Precision Medicine, Dna Sequencing, Rna Sequencing, Genome Editing, Crispr, Drug Discovery, Biopharma, Pharmaceutical Research, Molecular Biology, Genetic Testing, Next Generation Sequencing, Ngs, Biotech, Life Sciences, Therapeutics |
Looking for a particular QUiCKR Bio employee's phone or email?
Charles Blanluet is the CEO and Founder of QUiCKR Bio.
6 people are employed at QUiCKR Bio.